Guest guest Posted May 17, 2008 Report Share Posted May 17, 2008 This is only a small segment but here it is with a note from the FDA. These drugs can be quite dangerous when mixed with the Kundalini (which medical science doesnt recognize) as the abject physical or nueral pain combined with the tendancies towards suicide that these drugs exhibit as demonstrated in this clinical study can be amplified. [Posted 01/31/2008] FDA informed healthcare professionals that the Agency has analyzed reports of suicidality (suicidal behavior or ideation) from placebo-controlled clinical studies of eleven drugs used to treat epilepsy as well as psychiatric disorders, and other conditions. In the FDA's analysis, patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation (0.43%) compared to patients receiving placebo (0.22%). The increased risk of suicidal behavior and suicidal ideation was observed as early as one week after starting the antiepileptic drug and continued through 24 weeks. The results were generally consistent among the eleven drugs. The relative risk for suicidality was higher in patients with epilepsy compared to patients who were given one of the drugs in the class for psychiatric or other conditions. Healthcare professionals should closely monitor all patients currently taking or starting any antiepileptic drug for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression. The drugs included in the analyses include (some of these drugs are also available in generic form): Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR) Felbamate (marketed as Felbatol) Gabapentin (marketed as Neurontin) Lamotrigine (marketed as Lamictal) Levetiracetam (marketed as Keppra) Oxcarbazepine (marketed as Trileptal) Pregabalin (marketed as Lyrica) Tiagabine (marketed as Gabitril) Topiramate (marketed as Topamax) Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) Zonisamide (marketed as Zonegran) Although the 11 drugs listed above were the ones included in the analysis, FDA expects that the increased risk of suicidality is shared by all antiepileptic drugs and anticipates that the class labeling changes will be applied broadly. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic and http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 17, 2008 Report Share Posted May 17, 2008 Glad I quit taking Zonegran! I was taking it to reduce my migraines after the accident. I am having a lot of migraines recently but have managed to stay drug free. It isn't always easy, but I try to keep my eye on the goal. Overall though, I feel better than when I was taking all kinds of drugs. Sarita , " chrism " <> wrote: > > This is only a small segment but here it is with a note from the > FDA. These drugs can be quite dangerous when mixed with the > Kundalini (which medical science doesnt recognize) as the abject > physical or nueral pain combined with the tendancies towards suicide > that these drugs exhibit as demonstrated in this clinical study can > be amplified. > > [Posted 01/31/2008] FDA informed healthcare professionals that the > Agency has analyzed reports of suicidality (suicidal behavior or > ideation) from placebo-controlled clinical studies of eleven drugs > used to treat epilepsy as well as psychiatric disorders, and other > conditions. In the FDA's analysis, patients receiving antiepileptic > drugs had approximately twice the risk of suicidal behavior or > ideation (0.43%) compared to patients receiving placebo (0.22%). The > increased risk of suicidal behavior and suicidal ideation was > observed as early as one week after starting the antiepileptic drug > and continued through 24 weeks. The results were generally > consistent among the eleven drugs. The relative risk for suicidality > was higher in patients with epilepsy compared to patients who were > given one of the drugs in the class for psychiatric or other > conditions. > > Healthcare professionals should closely monitor all patients > currently taking or starting any antiepileptic drug for notable > changes in behavior that could indicate the emergence or worsening > of suicidal thoughts or behavior or depression. > > The drugs included in the analyses include (some of these drugs are > also available in generic form): > > Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol > XR) > Felbamate (marketed as Felbatol) > Gabapentin (marketed as Neurontin) > Lamotrigine (marketed as Lamictal) > Levetiracetam (marketed as Keppra) > Oxcarbazepine (marketed as Trileptal) > Pregabalin (marketed as Lyrica) > Tiagabine (marketed as Gabitril) > Topiramate (marketed as Topamax) > Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) > Zonisamide (marketed as Zonegran) > > Although the 11 drugs listed above were the ones included in the > analysis, FDA expects that the increased risk of suicidality is > shared by all antiepileptic drugs and anticipates that the class > labeling changes will be applied broadly. For more information visit > the FDA website at: > http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic > and > http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 18, 2008 Report Share Posted May 18, 2008 Hello, I have been using fever few for migraines and haven't had one for years. This is a herbal treatment which I prefer Love Liz Sarita <sarita1969 wrote: Glad I quit taking Zonegran! I was taking it to reduce my migraines after the accident. I am having a lot of migraines recently but have managed to stay drug free. It isn't always easy, but I try to keep my eye on the goal. Overall though, I feel better than when I was taking all kinds of drugs. Sarita , " chrism " <> wrote: > > This is only a small segment but here it is with a note from the > FDA. These drugs can be quite dangerous when mixed with the > Kundalini (which medical science doesnt recognize) as the abject > physical or nueral pain combined with the tendancies towards suicide > that these drugs exhibit as demonstrated in this clinical study can > be amplified. > > [Posted 01/31/2008] FDA informed healthcare professionals that the > Agency has analyzed reports of suicidality (suicidal behavior or > ideation) from placebo-controlled clinical studies of eleven drugs > used to treat epilepsy as well as psychiatric disorders, and other > conditions. In the FDA's analysis, patients receiving antiepileptic > drugs had approximately twice the risk of suicidal behavior or > ideation (0.43%) compared to patients receiving placebo (0.22%). The > increased risk of suicidal behavior and suicidal ideation was > observed as early as one week after starting the antiepileptic drug > and continued through 24 weeks. The results were generally > consistent among the eleven drugs. The relative risk for suicidality > was higher in patients with epilepsy compared to patients who were > given one of the drugs in the class for psychiatric or other > conditions. > > Healthcare professionals should closely monitor all patients > currently taking or starting any antiepileptic drug for notable > changes in behavior that could indicate the emergence or worsening > of suicidal thoughts or behavior or depression. > > The drugs included in the analyses include (some of these drugs are > also available in generic form): > > Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol > XR) > Felbamate (marketed as Felbatol) > Gabapentin (marketed as Neurontin) > Lamotrigine (marketed as Lamictal) > Levetiracetam (marketed as Keppra) > Oxcarbazepine (marketed as Trileptal) > Pregabalin (marketed as Lyrica) > Tiagabine (marketed as Gabitril) > Topiramate (marketed as Topamax) > Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) > Zonisamide (marketed as Zonegran) > > Although the 11 drugs listed above were the ones included in the > analysis, FDA expects that the increased risk of suicidality is > shared by all antiepileptic drugs and anticipates that the class > labeling changes will be applied broadly. For more information visit > the FDA website at: > http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic > and > http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 20, 2008 Report Share Posted May 20, 2008 I used to be on tegratol, I'm really glad I'm off of it now. I was was given it in high school to " calm down my nerves " lol. Yah, I was " out of control " but I think my parents, teachers, and doctors were out of control. I'm really curious to know how lithium is with the kundalini. I'm still waiting for my doctor to give me the OK on getting off this medication. I dont know whats taking so long. I can't tell if this drug is holding me back or not, or whether its causing some of my problems. This drug, lithium, with LSD can cause seizures and other things. I seriosuly think this drug intensfies effects of LSD, so I'm really curious what it does with kundalini experiences. , " chrism " <> wrote: > > This is only a small segment but here it is with a note from the > FDA. These drugs can be quite dangerous when mixed with the > Kundalini (which medical science doesnt recognize) as the abject > physical or nueral pain combined with the tendancies towards suicide > that these drugs exhibit as demonstrated in this clinical study can > be amplified. > > [Posted 01/31/2008] FDA informed healthcare professionals that the > Agency has analyzed reports of suicidality (suicidal behavior or > ideation) from placebo-controlled clinical studies of eleven drugs > used to treat epilepsy as well as psychiatric disorders, and other > conditions. In the FDA's analysis, patients receiving antiepileptic > drugs had approximately twice the risk of suicidal behavior or > ideation (0.43%) compared to patients receiving placebo (0.22%). The > increased risk of suicidal behavior and suicidal ideation was > observed as early as one week after starting the antiepileptic drug > and continued through 24 weeks. The results were generally > consistent among the eleven drugs. The relative risk for suicidality > was higher in patients with epilepsy compared to patients who were > given one of the drugs in the class for psychiatric or other > conditions. > > Healthcare professionals should closely monitor all patients > currently taking or starting any antiepileptic drug for notable > changes in behavior that could indicate the emergence or worsening > of suicidal thoughts or behavior or depression. > > The drugs included in the analyses include (some of these drugs are > also available in generic form): > > Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol > XR) > Felbamate (marketed as Felbatol) > Gabapentin (marketed as Neurontin) > Lamotrigine (marketed as Lamictal) > Levetiracetam (marketed as Keppra) > Oxcarbazepine (marketed as Trileptal) > Pregabalin (marketed as Lyrica) > Tiagabine (marketed as Gabitril) > Topiramate (marketed as Topamax) > Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) > Zonisamide (marketed as Zonegran) > > Although the 11 drugs listed above were the ones included in the > analysis, FDA expects that the increased risk of suicidality is > shared by all antiepileptic drugs and anticipates that the class > labeling changes will be applied broadly. For more information visit > the FDA website at: > http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic > and > http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 20, 2008 Report Share Posted May 20, 2008 Hello Drea, Many MDs do not like to see their patients come off the drugs they have precribed. Sometimes its an ego thing with them thinking that only they " know best " sometimes its that mixed in with other issues like their doubting your sanity with out the med. MDs have a problem sometimes with feeling that their way is the only way. Whatever the issue with your MD is you tell them to get on the stick! If they wont give you the reduction protocols then you can easily find one who will. - blessings Drea - chrism , " Drea " <lvledusa wrote: > I think my parents, teachers, and doctors > were out of control. > > I'm really curious to know how lithium is with the kundalini. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.